Risk of serotonin syndrome in acutely ill patients receiving linezolid and opioids concomitantly: a retrospective cohort study

INTRODUCTION: Linezolid is an oxazolidinone antibiotic with a reversible, non-selective, monoamine oxidase inhibitory effect. Combining linezolid with serotonergic agents may increase serotonin syndrome (SS) risk. Linezolid is recommended in patients with suspected or confirmed resistant Gram-positi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitwally, Hassan, Saad, Mohamed Omar, Alkhiyami, Dania, Fahmi, Amr Mohamed, Mahmoud, Sara, Hmoud, Eman Al, Enany, Rasha El, Younis, Hassan, Mohammed, Shaban, Rouf, Palli Abdul, Thomas, Binny, Hail, Moza Al
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618969/
https://www.ncbi.nlm.nih.gov/pubmed/36324824
http://dx.doi.org/10.1016/j.ijregi.2022.09.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618969/
https://www.ncbi.nlm.nih.gov/pubmed/36324824
http://dx.doi.org/10.1016/j.ijregi.2022.09.008

Ejemplares similares